Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing,
or coming back. The use of celecoxib may prevent or treat head and neck cancer.
PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works
compared to placebo in preventing head and neck cancer in patients with oral leukoplakia.